Repro Med Systems Stock Performance

KRMD Stock  USD 4.95  0.03  0.61%   
The company holds a Beta of 1.43, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Repro Med will likely underperform. At this point, Repro Med Systems has a negative expected return of -0.26%. Please make sure to check Repro Med's treynor ratio, kurtosis, relative strength index, as well as the relationship between the downside variance and day median price , to decide if Repro Med Systems performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Repro Med Systems has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's primary indicators remain rather sound which may send shares a bit higher in March 2026. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more

Actual Historical Performance (%)

One Day Return
3.14
Five Day Return
6.03
Year To Date Return
(12.30)
Ten Year Return
778.57
All Time Return
4.4 K
1
Heres Why You Should Retain CLOV Stock in Your Portfolio Now
12/18/2025
2
Insider Trading
12/29/2025
3
Koru Medical submits FreedomEDGE 510 premarket notification to the FDA - TipRanks
12/30/2025
4
Acquisition by Fletcher R John of 3872 shares of Repro Med at 5.81 subject to Rule 16b-3
01/02/2026
5
3 MedTech Stocks That Crushed the SP 500 Over the Past Year
01/09/2026
6
Analysts Offer Insights on Healthcare Companies Alphatec Holdings , Viridian Therapeutics and Enovis - The Globe and Mail
02/03/2026
7
An Intrinsic Calculation For KORU Medical Systems, Inc. Suggests Its 48 percent Undervalued
02/09/2026
8
Acquisition by Manko Joseph M. Jr. of 16 shares of Repro Med subject to Rule 16b-3
02/10/2026
9
Disposition of 750000 shares by Manko Joseph M. Jr. of Repro Med subject to Rule 16b-3
02/13/2026
Begin Period Cash Flow11.5 M
Total Cashflows From Investing Activities-1.3 M

Repro Med Relative Risk vs. Return Landscape

If you would invest  592.00  in Repro Med Systems on November 28, 2025 and sell it today you would lose (100.00) from holding Repro Med Systems or give up 16.89% of portfolio value over 90 days. Repro Med Systems is currently does not generate positive expected returns and assumes 2.9703% risk (volatility on return distribution) over the 90 days horizon. In different words, 26% of stocks are less volatile than Repro, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Repro Med is expected to under-perform the market. In addition to that, the company is 3.93 times more volatile than its market benchmark. It trades about -0.09 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.08 per unit of volatility.

Repro Med Target Price Odds to finish over Current Price

The tendency of Repro Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 4.95 90 days 4.95 
about 82.7
Based on a normal probability distribution, the odds of Repro Med to move above the current price in 90 days from now is about 82.7 (This Repro Med Systems probability density function shows the probability of Repro Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.43 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Repro Med will likely underperform. Additionally Repro Med Systems has an alpha of 0.0926, implying that it can generate a 0.0926 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Repro Med Price Density   
       Price  

Predictive Modules for Repro Med

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Repro Med Systems. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
1.914.887.85
Details
Intrinsic
Valuation
LowRealHigh
2.505.478.44
Details
Naive
Forecast
LowNextHigh
2.125.098.06
Details
5 Analysts
Consensus
LowTargetHigh
6.016.607.33
Details

Repro Med Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Repro Med is not an exception. The market had few large corrections towards the Repro Med's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Repro Med Systems, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Repro Med within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.09
β
Beta against Dow Jones1.43
σ
Overall volatility
0.52
Ir
Information ratio 0.04

Repro Med Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Repro Med for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Repro Med Systems can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Repro Med Systems generated a negative expected return over the last 90 days
The company reported the previous year's revenue of 33.65 M. Net Loss for the year was (6.07 M) with profit before overhead, payroll, taxes, and interest of 24.35 M.
Repro Med Systems currently holds about 18.27 M in cash with (319.72 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.41.
Roughly 57.0% of the company shares are owned by institutional investors
Latest headline from MacroaxisInsider: Disposition of 750000 shares by Manko Joseph M. Jr. of Repro Med subject to Rule 16b-3

Repro Med Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Repro Stock often depends not only on the future outlook of the current and potential Repro Med's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Repro Med's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding45.8 M
Cash And Short Term Investments9.6 M

Repro Med Fundamentals Growth

Repro Stock prices reflect investors' perceptions of the future prospects and financial health of Repro Med, and Repro Med fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Repro Stock performance.

About Repro Med Performance

By analyzing Repro Med's fundamental ratios, stakeholders can gain valuable insights into Repro Med's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Repro Med has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Repro Med has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 95.56  176.79 
Return On Tangible Assets(0.26)(0.25)
Return On Capital Employed(0.29)(0.28)
Return On Assets(0.26)(0.24)
Return On Equity(0.32)(0.31)

Things to note about Repro Med Systems performance evaluation

Checking the ongoing alerts about Repro Med for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Repro Med Systems help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Repro Med Systems generated a negative expected return over the last 90 days
The company reported the previous year's revenue of 33.65 M. Net Loss for the year was (6.07 M) with profit before overhead, payroll, taxes, and interest of 24.35 M.
Repro Med Systems currently holds about 18.27 M in cash with (319.72 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.41.
Roughly 57.0% of the company shares are owned by institutional investors
Latest headline from MacroaxisInsider: Disposition of 750000 shares by Manko Joseph M. Jr. of Repro Med subject to Rule 16b-3
Evaluating Repro Med's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Repro Med's stock performance include:
  • Analyzing Repro Med's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Repro Med's stock is overvalued or undervalued compared to its peers.
  • Examining Repro Med's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Repro Med's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Repro Med's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Repro Med's stock. These opinions can provide insight into Repro Med's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Repro Med's stock performance is not an exact science, and many factors can impact Repro Med's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Repro Stock analysis

When running Repro Med's price analysis, check to measure Repro Med's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repro Med is operating at the current time. Most of Repro Med's value examination focuses on studying past and present price action to predict the probability of Repro Med's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repro Med's price. Additionally, you may evaluate how the addition of Repro Med to your portfolios can decrease your overall portfolio volatility.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Bonds Directory
Find actively traded corporate debentures issued by US companies
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences